Andrew Kim
Psychiatry · Fort Worth, TXNPI 1124210109
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $136,126 of the $162,123 with a category attached, or 84.0%. Johnson & Johnson accounts for 97.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $39,988 and has fallen 77.5% since, to $8,992 in 2025. Among psychiatry clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $675.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$158K
- Janssen Scientific Affairs, LLC$3K
- Regeneron Healthcare Solutions, Inc.$701
- Alkermes, Inc.$118
- Zimmer Biomet$30
- Genentech USA, Inc.$24
- plus $22 from 1 others
Across 452 payments — averaging $4109.58 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$413K
- Otsuka Pharmaceutical Development & Commercialization, Inc.$374K
- Hoffmann-la Roche Limited$289K
- Sunovion Pharmaceuticals Inc.$227K
- Corcept Therapeutics$172K
- Teva Pharmaceuticals USA, Inc.$170K
- plus $213K from 8 others
What the payments were for
- Consulting fees$2,5912%
- Speaking & faculty fees$136,12684%
- Travel & lodging$18,34811%
- Food & beverage$5,0593%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 230 | $158,458 |
| Janssen Scientific Affairs, LLC | 5 | $2,771 |
| Regeneron Healthcare Solutions, Inc. | 1 | $701 |
| Alkermes, Inc. | 1 | $118 |
| Zimmer Biomet | 1 | $30 |
| Genentech USA, Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$156,677
- INVEGA SUSTENNA$2,591
- DUPIXENT$701
How this compares
$162,123 in reported general payments places this provider in the 95th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Fort Worth
- Rakesh JainLake Jackson$7.2M
- Arvinder Pal WaliaAustin$2.5M
- Suresh SureddiPlano$2.2M
- Martin GuerreroEl Paso$2M
- Marty BennettAddison$1.8M
- Matthew BramsHouston$1.5M
- Vikram MehraKaty$1.2M
- Joel HolinerDallas$948K
- Frank ChenHouston$941K
- Alice MaoHouston$850K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.